End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,430 KRW | +1.42% |
|
+3.54% | -35.05% |
04/07 | Genexine, Inc. Appoints Jaehyun Choi as Head of R&D | CI |
26/06 | Genexine, Inc. signed a letter of intent to acquire EPD Biotherapeutics Inc. for KRW25.6 billion. | CI |
Business Summary
Number of employees: 98
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Services
86.4
%
| 6,008 | 37.2 % | 3,825 | 86.4 % | -36.33% |
Technology Transfer
11.8
%
| 10,060 | 62.3 % | 524 | 11.8 % | -94.79% |
Other
1.7
%
| 72 | 0.4 % | 77 | 1.7 % | +7.49% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
60.5
%
| 4,486 | 27.8 % | 2,677 | 60.5 % | -40.31% |
South Korea
39.0
%
| 1,700 | 10.5 % | 1,724 | 39.0 % | +1.43% |
Asia
0.6
%
| 9,954 | 61.7 % | 25 | 0.6 % | -99.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gwang-Ho Kim
HRO | Human Resources Officer | 61 | - |
Kyu-Don Kim
PRN | Corporate Officer/Principal | 66 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Young-Jin Kim
CHM | Chairman | 67 | 20/15/20 |
Peter N. Laivins
BRD | Director/Board Member | 66 | - |
Jin-Geon Bae
BRD | Director/Board Member | 72 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,510,594 | 32,961,092 ( 79.40 %) | 60,816 ( 0.1465 %) | 79.40 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
TOOLGEN INCORPORATED 14.08% | 1,118,347 | 14.08% | 55,165,832 $ |
GI INNOVATION, INC. 0.69% | 303,030 | 0.69% | 2,285,107 $ |
Company contact information
![address Genexine, Inc.(A095700)](https://cdn.zonebourse.com/static/address/20705487.png)
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.05% | 193M | |
+16.61% | 122B | |
+17.75% | 112B | |
+18.89% | 25.91B | |
-24.11% | 19.33B | |
-17.80% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- A095700 Stock
- Company Genexine, Inc.